Related Experiment Video
Updated: Jul 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function
L M S Lau1, J K Nugent, X Zhao
1Division of Hematology/Oncology, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Ontario, Canada.
Abstract:
Nutlin-3, a small molecule inhibitor, activates p53 by disrupting p53-HDM2 association. In this study, we found that Nutlin-3 suppressed cell growth and induced apoptosis in the absence of wild-type p53, suggesting a p53-independent mechanism for Nutlin-3-induced cell death. Like p53, its homolog p73 transactivates proapoptotic genes and induces cell death. Since HDM2, a key negative regulator of p53, also binds to and inhibits p73, we asked whether p73 could mediate Nutlin-3-induced apoptosis. We demonstrate that Nutlin-3 inhibits endogenous binding between the proapoptotic p73 isoform TAp73alpha and HDM2 in p53-null cells. Dissociation of p73 and HDM2 leads to increased p73 transcriptional activity with upregulation of p73 target genes noxa, puma and p21, as well as enhanced apoptosis. p73 knockdown by siRNA results in rescue of Nutlin-3-treated cells, indicating that Nutlin-3-induced apoptosis is, at least in part, p73 dependent. In addition, Nutlin-3 treatment increases TAp73alpha protein levels with prolongation of p73 half-life. These results provide the first evidence that Nutlin-3 disrupts endogenous p73-HDM2 interaction and enhances the stability and proapoptotic activities of p73 and thus, provides a rationale for the use of Nutlin-3 in the large number of human tumors in which p53 is inactivated.
Insights
Nutlin-3 triggers cell death independently of p53 by targeting p73. This small molecule inhibitor disrupts the p73-HDM2 interaction, enhancing p73
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Mechanisms
Background:
- Nutlin-3 is a small molecule inhibitor known to activate p53 by disrupting its association with HDM2.
- p53-null cancer cells exhibit Nutlin-3-induced cell death, suggesting a p53-independent mechanism.
- p73, a homolog of p53, also induces apoptosis and is negatively regulated by HDM2.
Purpose of the Study:
- To investigate whether p73 mediates Nutlin-3-induced apoptosis in p53-null cells.
- To elucidate the mechanism of Nutlin-3 action in the context of p53 inactivation.
Main Methods:
- Assessed the interaction between p73 and HDM2 in p53-null cells treated with Nutlin-3.
- Measured the transcriptional activity of p73 and the expression of its target genes (noxa, puma, p21).
- Utilized siRNA to knock down p73 and evaluated the effect on Nutlin-3-induced apoptosis.
- Determined the impact of Nutlin-3 on TAp73alpha protein levels and half-life.
Main Results:
- Nutlin-3 inhibited the binding of the proapoptotic p73 isoform TAp73alpha to HDM2 in p53-null cells.
- This dissociation led to increased p73 transcriptional activity, upregulating target genes noxa, puma, and p21.
- Nutlin-3 treatment enhanced apoptosis, which was partially rescued by p73 knockdown.
- Nutlin-3 increased TAp73alpha protein levels and prolonged its half-life.
Conclusions:
- Nutlin-3 disrupts the endogenous p73-HDM2 interaction, enhancing p73 stability and proapoptotic activity.
- This p73-dependent mechanism provides a rationale for using Nutlin-3 in human tumors with p53 inactivation.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
